Literature DB >> 27979841

Modeling Alveolar Soft Part Sarcoma Unveils Novel Mechanisms of Metastasis.

Miwa Tanaka1, Mizuki Homme1, Yukari Yamazaki1, Rikuka Shimizu1, Yutaka Takazawa2, Takuro Nakamura3.   

Abstract

Alveolar soft part sarcoma (ASPS) is a slowly growing, but highly metastatic, sarcoma that affects adolescents and young adults. Its characteristic alveolar structure is constituted by tumor cell nests and an abundant vascular network that is responsible for metastatic activities at the initial stage. Here, we have generated a new ex vivo mouse model for ASPS that well recapitulates associated angiogenic and metastatic phenotypes. In mouse ASPS, the tumor cells frequently showed tumor intravasation, with the intravascular tumor cells presenting as organoid structures covered with hemangiopericytes, which is also observed in human ASPS. High expression of glycoprotein nmb (GPNMB), a transcriptional target of ASPSCR1-TFE3, was observed at the sites of intravasation. ASPS tumor cells also demonstrated enhanced transendothelial migration activity, which was inhibited by silencing of Gpnmb, indicating that GPNMB plays an important role in tumor intravasation, a key step in cancer metastasis. The present model also enabled the evaluation of TFE/MITF family transcription factor function, which demonstrated that ASPSCR1-TFEB possessed definitive albeit less marked oncogenic activity than that of ASPSCR1-TFE3. Collectively, our mouse model provides a tool to understand oncogenic, angiogenic, and metastatic mechanisms of ASPS. It also identifies important motifs within the ASPSCR1-TFE3 fusion protein and provides a platform for developing novel therapeutic strategies for this disorder. Cancer Res; 77(4); 897-907. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27979841     DOI: 10.1158/0008-5472.CAN-16-2486

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  CIC-DUX4 Induces Small Round Cell Sarcomas Distinct from Ewing Sarcoma.

Authors:  Toyoki Yoshimoto; Miwa Tanaka; Mizuki Homme; Yukari Yamazaki; Yutaka Takazawa; Cristina R Antonescu; Takuro Nakamura
Journal:  Cancer Res       Date:  2017-04-12       Impact factor: 12.701

Review 2.  Regulation of TFEB activity and its potential as a therapeutic target against kidney diseases.

Authors:  Weihuang Zhang; Xiaoyu Li; Shujun Wang; Yanse Chen; Huafeng Liu
Journal:  Cell Death Discov       Date:  2020-05-01

3.  Fusion of the Genes PHF1 and TFE3 in Malignant Chondroid Syringoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Marius Lund-Iversen; Assia Bassarova; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

4.  TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease.

Authors:  Masaya Baba; Mitsuko Furuya; Takanobu Motoshima; Martin Lang; Shintaro Funasaki; Wenjuan Ma; Hong-Wei Sun; Hisashi Hasumi; Ying Huang; Ikuma Kato; Tsuyoshi Kadomatsu; Yorifumi Satou; Nicole Morris; Baktiar O Karim; Lilia Ileva; Joseph D Kalen; Luh Ade Wilan Krisna; Yukiko Hasumi; Aiko Sugiyama; Ryoma Kurahashi; Koshiro Nishimoto; Masafumi Oyama; Yoji Nagashima; Naoto Kuroda; Kimi Araki; Masatoshi Eto; Masahiro Yao; Tomomi Kamba; Toshio Suda; Yuichi Oike; Laura S Schmidt; W Marston Linehan
Journal:  Mol Cancer Res       Date:  2019-05-01       Impact factor: 5.852

5.  Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo.

Authors:  Denise Garcia; Patrick Nasarre; Ingrid V Bonilla; Eleanor Hilliard; Yuri K Peterson; Laura Spruill; Anne-Marie Broome; Elizabeth G Hill; Jason T Yustein; Shikhar Mehrotra; Nancy Klauber-DeMore
Journal:  Ann Surg Oncol       Date:  2019-09-12       Impact factor: 5.344

6.  Loss of Hepatic Transcription Factor EB Attenuates Alcohol-Associated Liver Carcinogenesis.

Authors:  Xiaojuan Chao; Shaogui Wang; Madeline Hlobik; Andrea Ballabio; Hong-Min Ni; Wen-Xing Ding
Journal:  Am J Pathol       Date:  2021-10-27       Impact factor: 4.307

7.  MiT/TFE Family of Transcription Factors, Lysosomes, and Cancer.

Authors:  Rushika M Perera; Chiara Di Malta; Andrea Ballabio
Journal:  Annu Rev Cancer Biol       Date:  2018-11-28

8.  HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin.

Authors:  Marco Biondini; Alex Kiepas; Leeanna El-Houjeiri; Matthew G Annis; Brian E Hsu; Anne-Marie Fortier; Geneviève Morin; José A Martina; Isabelle Sirois; Adriana Aguilar-Mahecha; Tina Gruosso; Shawn McGuirk; April A N Rose; Unal M Tokat; Radia M Johnson; Ozgur Sahin; Eric Bareke; Julie St-Pierre; Morag Park; Mark Basik; Jacek Majewski; Rosa Puertollano; Arnim Pause; Sidong Huang; Tibor Keler; Peter M Siegel
Journal:  Oncogene       Date:  2022-02-02       Impact factor: 8.756

9.  Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials.

Authors:  Roman Groisberg; David S Hong; Amini Behrang; Kenneth Hess; Filip Janku; Sarina Piha-Paul; Aung Naing; Siqing Fu; Robert Benjamin; Shreyaskumar Patel; Neeta Somaiah; Anthony Conley; Funda Meric-Bernstam; Vivek Subbiah
Journal:  J Immunother Cancer       Date:  2017-12-19       Impact factor: 13.751

10.  Lingual alveolar soft part sarcoma with absent TFE3 rearrangement.

Authors:  Saeed Alshahrani; Abdullatif Khan
Journal:  Cancer Rep (Hoboken)       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.